TECARTUS
Google image searchProduct monograph
Active ingredient
brexucabtagene autoleucel, 100000000 CELLS/BAG
DIN: 02532719
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription / Schedule D
Company: GILEAD SCIENCES CANADA INC
Date: 15-DEC-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XL — Antineoplastic cell and gene therapy (ATC, ATC/DDD)
- L01XL06 — BREXUCABTAGENE AUTOLEUCEL (ATC/DDD)
